Dr. Nihal AYDEMİR
01.12.2022




  • Başlıksız-1 kopya.jpg

CURRICULUM VITAE

Surname, NameAydemir (Ozkayar), Nihal, MD
Place & Date of BirthAnkara/Turkey,27.06.1977
NationalityTurkish
GenderFemale
Academic DegreeProf. 

Education and Training
2009 2013Nephrology Fellowship Ankara Numune Education and ResearchHospital,Department of Nephrology(Ankara/Turkey)
2001¬ 2005Internal Medicine ResidencyHacettepe University,Faculty of MedicineDepartment of Internal Medicine(Ankara/Turkey)
1994 2000Gazi UniversityFaculty of Medicine (Ankara/Turkey)
1991  1994Ankara Incirli High School (Ankara/Turkey)
Work Experience
2021-present    Nephrologist, Assoc. ProfHitit University Medical Faculty Corum Training and Research Hospital(Corum/Turkey)

2018-2021                               Nephrologist, Assoc. ProfHitit University Medical Faculty Corum Training and Research Hospital(Corum/Turkey)

2017-2018Visiting ScholarVanderbilt University School ofMedicine, Department of Nephrologyand Transplantation (Tennessee/USA)
2016 (April) -2017Nephrologist, Assoc. ProfHitit University Medical Faculty Corum Training and Research Hospital(Corum/Turkey)
20132015NephrologistAnkara Numune Education and        Research Hospital, Department of Nephrology (Ankara/Turkey)
2009 2013ResidencyAnkara Numune Education and        Research Hospital, Department of Nephrology (Ankara/Turkey)
20052009Internist,MDCebeci Medical Center, Department of Internal Medicine (Ankara/Turkey)
2001 ¬ 2005ResidencyHacettepe University, Faculty of Medicine,Department of Internal Medicine (Ankara/Turkey) 
Publications
1.Aydemir N, Pike MM, Alsouqi A, Headley SAE, Tuttle K, Evans EE, Milch CM, Moody KA, Germain M, Lipworth L, Himmelfarb J, Ikizler TA, Robinson-Cohen C. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease.Nutr Metab Cardiovasc Dis 24;30(8):1375-1381 (2020) 
2.Ozkayar N, Dede F, Ates I, Akyel F, Yildirim T, Altun B. ‘’The relationship between dietary salt intake and ambulatory blood pressure variability in non-diabetic hypertensive patients. ‘’Nefrologia. 36(6): 694-700 (2016)
3.Ozkayar N, Akyel S, Dede F, Akyel F, Turgut D, Bulut M, Odabaş AR.“Evaluation of heart rate recovery in patients with primary nephrotic syndrome.”Hippokratia 19, 2: 109-113 (2015).
4.Ateş I, Ozkayar N, Altay M,Yilmaz F.M,  Topçuoğlu C, Alışık M,  Erel O,Dede F.  “Is disulphide/thiol ratio related to blood pressurein masked hypertension? ” Clin Exp Hypertens, 38: 150–154 (2016.)
5.Inan B, Ates I, Ozkayar N, Kundi H, Topcuoglu C,Dede F, Sennaroglu  E. “Are increased oxidative stress and asymmetric dimethylarginine levels associated with masked hypertension?”Clin Exp Hypertens, 38:3, 294-298 (2016)
6.Ates I, Bulut M, Ozkayar N, Dede F. “Association Between High Platelet Indices and Proteinuria in Patients with Hypertension”Ann Lab Med, 35:630-634 (2015)
7.Ates I, Ozkayar N, Toprak G, Yılmaz N, Dede F. “Factors associated with mortality in patients presenting to the emergency department with severe hypernatremia” Intern Emerg Med 11:451–459 (2016)
8.Ates I, Ozkayar N, Topcuoglu C,Dede F. “Relationship between oxidative stress parametersand asymptomatic organ damage in hypertensive patients without diabetes mellitus”. Scand Cardiovasc J,49:5,249-250 (2016)
9.Kundi H,Kiziltunc E, Ates I, Cetin M,  Barca N.A., Ozkayar N, Ornek E. “Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients”. Endoc Res Apr 25:1-6(2016)
10.Rona G, Pasaoglu L, Ozkayar N, Ciliz D, Toprak U, Kaya T, Abat G. “Functional evaluation of secondary renal amyloidosis with diffusion-weighted MR imaging” Renal Failure 38:2, 249-255 (2016)
11.Piskinpasa S, Agbaht K, Akoglu H, Akyel F, Ozkayar N, Coskun E , Turgut D,  Koc E, Odabas A.R, Dede F. “ Unknown aspect of the old disease: doesdyslipidemia in systemic AA amyloidosis differ from the dyslipidemia in primary glomerulonephritis?” Renal Failure, 37:8, 1273-1279 (2015)
12.Bayrakci N, Ozkayar N, Ersozen ME, Colak A, Oguz EG, Dede. “Coexistence of Immunoglobulin M Nephropathy and Autoimmune Hemolytic Anemia Two Rare Entities ”IJKD, 9:472-9 (2015)
13.Yenigun EC, Bayrakci N, Cevher SK, Ozkayar N, Dede F. “Systemic Lupus Erythematosus as a Rare Cause of Anemia Resistant to Erythropoiesis-stimulating Agents. ”IJKD, 10:97-9 (2016)
14.Bayrakci N, Ozkayar N, Akyel F, Ates I, Akyel S, Dede F“The platelet-to-lymphocyte ratio as an inflammation marker in non-dipper hypertensive patients” Hippokratia 19,2:114-118 (2015)
15.Ates I, Ozkayar N, Inan B, Yilmaz F.M, Topcuoglu C, Neselioglu S, Erel O, Dede F, Yilmaz N. “Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension” Journal of the American Society of Hypertension 10:159–166 (2016)
16.Ozkayar N, Piskinpasa S, Akyel F, Turgut D, Bulut M, Turhan T, Dede F. “Relation Between Serum Cathepsin D Levels and Endothelial Dysfunction In Patients With Chronic Kidney Disease.” Nefrologia, 35, 72-79 (2015).
17.Ates I, Altay M, Kaplan M, Ozkayar N, Toprak G, Alaguney ME, Ozkara A. “The Relationship between Socioeconomic Level, and the Prevalence of Masked Hypertension and Asymptomatic Organ Damage,” Med Sci Monit, 8,21, 1022-1030 (2015).
18.Ates I, Ozkayar N, Topcuoglu C, Dede F. “Relationship between oxidative stress parameters and asymptomatic organ damage in hypertensive patients without diabetes mellitus,”Scand Cardiovasc J, 8,1-23 (2015).
19.Ozturk R, Yenigun EC, Dede F, Koc E, Turgut D, Piskinpasa SV, Ozkayar N, Odabas AR. “Prognostic factors in crescentic glomerulonephritis: a single-center experience,” Iran J Kidney Dis, 9,31-38 (2015).
20.Ates I, Ozkayar N,Akyel F, Topcuoglu C, Akyel S, Barça N, Dede F. “The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients,” BMC Nephrology,15,159 (2014).
21.Ozkayar N, Altun B, Yildirim T, Yilmaz R, Dede F, Arik G, Turkmen E, Hayran M, Aki FT, Arici M, Erdem Y. “Blood pressure measurements, blood pressure variability and endothelial function in renal transplant recipients,” Clin Exp Hypertens, 36,392-397, (2014).
22.Ozkayar N, Barça N, Akyel F, Turgut D,Yenigün EC, Turhan T, Dede F. “The relationship between the serum uric acid level, neutrophil-lymphocyte ratio, and carotid intima media thickness in chronic kidney disease,” Acta Medica Mediterranea, 30,1239 (2014).
23.Ozkayar N, Altun B, Ulusoy S, Yildirim T, Halil M, Yilmaz, Abudalal A, Altindal A, Arici M, Erdem Y. “Relationship between Vitamin D Levels and Depressive Symptoms in Renal Transplant Recipients,” Int J Psychiatry Med, 47,141-151 (2014).
24.Ozkayar N, Altun B, Halil M, Kuyumcu ME, Arık G, Yeşil Y, Yıldırım T, Yılmaz R, Arıoğul S, Turgan C. “Evaluation of Sarcopenia in Renal Transplant Recipients,” Nephrourol Mon, 6:e20055 (2014).
25.Ozkayar N, Piskinpasa S, Bulut M, Oğuz E, Turhan T, Doğan HO, Dede F. “A Very Rare Complication of Carbon Monoxide Intoxication; Thrombotic Thrombocytopenic Purpura,” Turk J Biochem, 39, 571–573 (2014).
26.Cevher SK, Ozkayar N, Dede F. “Allergic rash caused by icodextrin,” Case Rep Nephrol Dial, 5, 26-29 (2014).
27.Yenigun EC, Dede F, Ozkayar N, Turgut D, Piskinpasa SV, Ozturk R, Koc E, Odabas AR, “Coexistence of autosomal dominant polycystic kidney disease and amyloidosis in a patient with nephrotic-range proteinuria,” Iran J Kidney Dis, 8, 243-245 (2014).
28.Ozkayar N, Piskinpasa S, Akyel F, Dede F, Yildirim T, Turgut D, Koc E, Haznedaroglu IC. “Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever,”  Rheumatol Int, 33, 2555-2559 (2013).
29.Piskinpasa S, Akoglu H, Koc E, Dogru F, Coskun EY, Turgut D, Ozkayar N, Ozturk R, Odabas AR, Dede F. “Revisiting secondary amyloidosis for an inadequately investigated feature: dyslipidemia,”Rheumatol Int, 33, 993-999 (2013).
30.Ulger Z, Ariogul S, Cankurtaran M, Halil M, Yavuz BB, Orhan B, Kavas GO, Aribal P, Canlar S, Dede DS, Ozkayar N, Akyol O. “Intra-erythrocyte magnesium levels and their clinical implications in geriatric outpatients,” J Nutr Health Aging, 14, 810-814( 2010).
31.Yavuz BB, Ozkayar N, Halil M, Cankurtaran M, Ulger Z, Tezcan E, Gurlek A, Ariogul S. “Free testosterone levels and implications on clinical outcomes in elderly men,” Aging Clin Exp Res, 20, 201-206 (2008).
32.Yönem O, Ozkayar N, Balkanci F, Harmanci O, Sökmensüer C, Ersoy O, Bayraktar Y. “Is congenital hepatic fibrosis a pure liver disease? ,” Am J Gastroenterol, 101,1253-1259 (2006).
33.Halil M, Cankurtaran ES, Ozkayar N, Cankurtaran M, Ulger Z, Yavuz BB, horbagi A, Ariogul S. “Elderly patient with delirium after myocardial infarction,”J Natl Med Assoc, 98, 648-650 (2006).
34.Halil M, Ulger Z, Cankurtaran M, Shorbagi A, Yavuz BB, Dede D, Ozkayar N, Ariogul S.Falls and the elderly: is there any difference in the developing world? A cross-sectional study from Turkey,”Arch Gerontol Geriatr, 43, 351-359, (2006).
35.Odabaşi M, Ozkayar N, Ozkara S, Unal S, Denizli A. “Pathogenic antibody removal using magnetically stabilized fluidized bed,” J Chromatogr B Analyt Technol Biomed Life Sci, 826, 50-57 (2005).
 
Presentations
1.Ozkayar N, Ates I, Akyel F, Tayman C, Namuslu M, Barça N, Akyel S, Dede F, “The relationship between the subclinical target organ damage and the levels of ischemia-modified albumin in hypertensive patients,” 17th European Congress of Endocrinology,Ireland, May 2015
2.Ates I, Altay M, Kaplan M, Ozkayar N, Toprak G, Alaguney ME, Ozkara A, “The Relationship between Socioeconomic Level, and the Prevalence of Masked Hypertension and Asymptomatic Organ Damage,” 17th European Congress of Endocrinology, Ireland, May 2015
3.Ates I, Ozkayar N,Topcuoğlu C, Dede F, “The serum irisin level in non-diabetic patients with chronic kidney disease,” 17th European Congress of Endocrinology, Ireland, May 2015
4.BayrakçıN,Ateş I, Ozkayar N, YılmazFM, Topçuoğlu C, Neşelioğlu S, Ozcan Erel O, AltayM, “Dynamic Thiol/Disulfide Homeostasis In Patients With Newly Diagnosed Type 2 Diabetes Mellitus,” 17th European Congress of Endocrinology, Ireland, May 2015
5.Ates I, Altay M, Kaplan M, Ozkayar N, Alagüney ME, Dede F, Ozkara A, “Is thyroid function related to masked hypertension?,” 17th European Congress of Endocrinology, Ireland, May 2015
6.Ozkayar N, Altun B, Yildirim T, Yilmaz R, Dede F, Hayran M, Arici M, Aki T, Erdem Y, “Relationship between blood pressure values, blood pressure variability and endothelial functions in renal transplant recipients,” ERA-EDTA 50th Congress,Turkey, May, 2013. Nephrol Dial Transplant;28(S1):i85-i86 (2013)
7.Halil M, Durukan B, Cankurtaran M, Yavuz B, Ülger Z, Altinbaş A, Ozkayar N, Böke E, Arioğul S, “ Relationship between cardiovascular risk factors and ankle brachial index in the elderly,”  2nd Clinical Vascular Biology Congress, Turkey,2006.European Journal of Clinical Invastigation, 36, 267 (2006)
8.Ulger Z, M. Halil, M. Cankurtaran, B.B. Yavuz, D. Dede, N. Ozkayar, S. Arıogul, “Risk factors and predictors of hypertension in the elderly; a cross-sectional study from Turkey ’’, 15th European Meeting on Hypertension; Milan-Italy, 2005. J Hypertension, 23:195 (2005)
9.Dede D, M. Halil, M. Cankurtaran, B.B. Yavuz, Z. Ulger, N. Ozkayar, S. Arıogul. “Is there any relation between osteoporosis and C - reactive protein in elderly patients? ’’,  2nd Joint Meeting of the European Calcified Tissue Society and the International Bone and Mineral Society; Geneva-Switzerland, 2005. Bone;36,334(2005)
Awards
-Seref Zileli “Best Resident of the Year” Award, Hacettepe University, Faculty of Medicine, Department of Internal Medicine (2005)
Affiliations & Associations
-Turkish Society of Nephrology 
-Turkish Society of Hypertension and Renal Diseases
-
Contact Information
Work Address:Hitit Üniversitesi Tıp Fakültesi Çorum Eğitim ve Araştırma Hastanesi İç Hastalıkları Anabilim Dalı, Nefroloji Bölümü Merkez/ÇORUM,TÜRKİYE
Cell Phone:005064813420
E-mail:nihalozk@gmail.com


  Treatments Applied In Our Nephrology Clinic
Hypertension Treatment
Acute Kidney Failure Treatment
Chronic Kidney Failure Treatment
Hemodialysis
Peritoneal Dialysis
Home Hemodialysis
Kidney Biopsy
Glomerulonephritis Treatment
Temporary Central Venous Catheter Insertion
Permanent Central Venous Catheter Insertion
Arteriovenous Fistüla Managment